A detailed history of Dash Acquisitions Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Dash Acquisitions Inc. holds 1,960 shares of NVO stock, worth $205,917. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,960
Previous 1,962 0.1%
Holding current value
$205,917
Previous $280,000 16.79%
% of portfolio
0.06%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$119.07 - $145.42 $238 - $290
-2 Reduced 0.1%
1,960 $233,000
Q2 2024

Jul 18, 2024

SELL
$122.71 - $146.91 $3,681 - $4,407
-30 Reduced 1.51%
1,962 $280,000
Q1 2024

Apr 18, 2024

BUY
$102.11 - $135.92 $3,880 - $5,164
38 Added 1.94%
1,992 $255,000
Q4 2023

Jan 17, 2024

BUY
$87.78 - $105.45 $171,522 - $206,049
1,954 New
1,954 $202,000
Q1 2023

Apr 05, 2023

BUY
$132.34 - $159.14 $180,379 - $216,907
1,363 New
1,363 $216,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Dash Acquisitions Inc. Portfolio

Follow Dash Acquisitions Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dash Acquisitions Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dash Acquisitions Inc. with notifications on news.